Year archive

Bright Minds Biosciences Inc. — 2022 filings

All 45 regulatory filings released by Bright Minds Biosciences Inc. (DRUG) in 2022, sourced directly from the official regulator.

45 Filings

2022 Period

2022 filings (45)

Filing	Released	Lang
Annual information form - English.pdf Regulatory Filings	2022-12-30	English
52-109F1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2022-12-30	English
52-109F1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2022-12-30	English
Annual MD&A - English.pdf Regulatory Filings	2022-12-30	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2022-12-30	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2022-12-30	English
Audited annual financial statements – English.pdf Regulatory Filings	2022-12-30	English
News release - English.pdf Capital/Financing Update	2022-12-03	English
News release - English.pdf Board/Management Information	2022-11-23	English
News release - English.pdf Regulatory Filings	2022-08-31	English
Material change report - English.pdf Capital/Financing Update	2022-08-26	English
Non-issuer's submission to jurisdiction and appointment of agent.pdf Regulatory Filings	2022-08-26	English
Consent letter of underwriters' legal counsel.pdf Regulatory Filings	2022-08-26	English
Auditors' consent letter.pdf Regulatory Filings	2022-08-26	English
Underwriting or agency agreements (or amendment thereto).pdf Regulatory Filings	2022-08-26	English
Prospectus (non pricing) supplement (other than ATM) – English.pdf Regulatory Filings	2022-08-26	English
Consent letter of issuer's legal counsel.pdf Regulatory Filings	2022-08-26	English
Other.pdf Capital/Financing Update	2022-08-26	English
News release - English.pdf Capital/Financing Update	2022-08-24	English
News release - English.pdf Capital/Financing Update	2022-08-23	English
52-109F2R - Certification of refiled interim filings - CEO (E).pdf Regulatory Filings	2022-08-13	English
52-109F2R - Certification of refiled interim filings - CFO (E).pdf Regulatory Filings	2022-08-13	English
Interim financial statements/report (amended) - English.pdf Regulatory Filings	2022-08-13	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-08-12	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2022-08-12	English
Interim MD&A - English.pdf Regulatory Filings	2022-08-12	English
Interim financial statements/report – English.pdf Regulatory Filings	2022-08-12	English
News release - English.pdf Board/Management Information	2022-06-27	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-05-17	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2022-05-17	English
Interim MD&A - English.pdf Regulatory Filings	2022-05-17	English
Interim financial statements/report – English.pdf Regulatory Filings	2022-05-17	English
Interim financial statements/report – English.pdf Regulatory Filings	2022-05-17	English
Interim MD&A - English.pdf Regulatory Filings	2022-05-17	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2022-05-17	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-05-17	English
News release - English.pdf Investor Presentation	2022-04-19	English
News release - English.pdf Capital/Financing Update	2022-03-14	English
News release - English.pdf Investor Presentation	2022-03-08	English
Other.pdf Regulatory Filings	2022-02-15	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2022-02-15	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-02-15	English
Interim MD&A - English.pdf Regulatory Filings	2022-02-15	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2022-02-15	English
News release - English.pdf Investor Presentation	2022-01-04	English